Insider · CIK 0001863676
Samuel C. Blackman
Files at DAWN (Day One Biopharmaceuticals, Inc.). First filing Nov 4, 2024, latest Dec 12, 2024.
In brief
Samuel C. Blackman files SEC Form 4 as officer at DAWN (Day One Biopharmaceuticals, Inc.). Since Nov 4, 2024, Samuel C. Blackman has reported 0 open-market buys worth $0 and 5 open-market sells worth $1.1M, the latest filed on Dec 12, 2024.
A track record needs three past buys with six months of prices behind them; Samuel C. Blackman has 0, so none is measured yet.
The newest scored trade: sold $399k of DAWN on Dec 10, 2024, filed Dec 12, 2024, scored 11 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | Day One Biopharmaceuticals, Inc. | $399k 30,000 shares | -3% | - | |
| 20Weak | Day One Biopharmaceuticals, Inc. | $29k 2,206 shares | -0% | - | |
| 27Weak | Day One Biopharmaceuticals, Inc. | $456k 28,255 shares | -3% | - | |
| 22Weak | Day One Biopharmaceuticals, Inc. | $180k 11,245 shares | -1% | - | |
| 0Weak | Day One Biopharmaceuticals, Inc. | $8,010 500 shares | -0% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 18, 2024 | DAWN DAY ONE BIOPHARMACEUTICALS, INC. | 2,206 0.00% of outstanding | $29k | Nov 18, 2024 | $1.1M |
| Nov 12, 2024 | DAWN DAY ONE BIOPHARMACEUTICALS INC | 50,000 0.05% of outstanding | $820k | Nov 11, 2024 | $941k |
| Oct 31, 2024 | DAWN DAY ONE BIOPHARMACEUTICALS INC | 30,000 0.03% of outstanding | $434k | Oct 31, 2024 | $458k |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -30,000 | $13.31 | $399k | 1,034,015 | Dec 12, 2024 |
| Nov 15, 2024 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +1,187 | - | - | 1,058,722 | Nov 19, 2024 |
| Nov 15, 2024 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +1,437 | - | - | 1,060,159 | Nov 19, 2024 |
| Nov 15, 2024 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Common Stock | +6,062 | - | - | 1,066,221 | Nov 19, 2024 |
| Nov 18, 2024 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,206 | $13.21 | $29k | 1,064,015 | Nov 19, 2024 |
| Nov 15, 2024 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -1,187 | $0.00 | $0 | 4,756 | Nov 19, 2024 |
| Nov 15, 2024 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -1,437 | $0.00 | $0 | 11,504 | Nov 19, 2024 |
| Nov 15, 2024 | DAWN Day One Biopharmaceuticals, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -6,062 | $0.00 | $0 | 72,752 | Nov 19, 2024 |
| Nov 8, 2024 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -18,255 | $16.17 | $295k | 1,067,535 | Nov 12, 2024 |
| Nov 11, 2024 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $16.10 | $161k | 1,057,535 | Nov 12, 2024 |
| Nov 7, 2024 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -11,245 | $16.03 | $180k | 1,085,790 | Nov 8, 2024 |
| Oct 31, 2024 | DAWN Day One Biopharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -500 | $16.02 | $8,010 | 1,097,035 | Nov 4, 2024 |
Questions about Samuel C. Blackman
Answered from the filings on this page, as of the latest one.
Is Samuel C. Blackman buying or selling?
Not in the last 12 months. Samuel C. Blackman's latest open-market trade on SEC Form 4 was sold $399k of DAWN on Dec 10, 2024.
How did Samuel C. Blackman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Samuel C. Blackman has 0.
Where does Samuel C. Blackman file Form 4?
Samuel C. Blackman has filed Form 4 at DAWN (Day One Biopharmaceuticals, Inc.) as HEAD OF R&D. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.